As States Legalize companies, Investors See an Opportunity

companies s the world's most commonly cultivated, trafficked, and used illicit drug, and as the push for legalization at home and abroad grows, companies is garnering significant attention from investors, manufacturers, and researchers. Despite the plant being illegal under federal law as a Schedule I drug, the U.S. legal companies industry was estimated at $10.4 billion in 2018 with 250,000 jobs devoted to the handling of plants, according to New Frontier Data. A total of 33 states have legalized companies for medical use, 10 of which allow adults to legally use the drug for recreational use. And that number may continue to rise, as more people are accepting the idea of legalizing companies across the United States. This article looks at some of the uses of companies as well as the overall market for the drug.